Is ITGR a buy according to AI stock analysis?

ITGR AI stock analysis does not label the stock a simple buy. The KKR offer of $127 per share in cash anchors the value, and the stock closed at $124.45 on August 3, 2026, about 2% below the offer. The decision is now mostly a judgment about whether the deal closes, so investors should weigh deal-completion risk and their own horizon rather than a classic valuation call.

What is the ITGR AI stock forecast?

The ITGR AI stock forecast is structured around the $127 cash offer. The base case is $120 to $127 as the stock trades near the offer while the proxy, stockholder vote, and regulatory review progress, the bullish case is $127 to $132 if the deal closes or a higher bid emerges, and the bearish case is $90 to $110 if the deal fails and the stock reverts toward the $95 to $100 pre-announcement range.

What technical levels matter for ITGR?

The key ITGR technical levels are support near $120 to $121 from the July 31 close, secondary support at $113 to $116, and the $125.54 52-week high plus the $127 offer as the resistance ceiling. A close below $120 weakens the setup, and a break below $113 to $116 points to a return toward pre-deal levels.

Can AI predict ITGR stock price?

No, AI cannot reliably predict stock prices. AI can organize deal terms, financial filings, market data, valuation math, technical levels, and risk scenarios, but ITGR can still move sharply on stockholder vote news, regulatory decisions, competing bids, or any development that changes the odds of the KKR deal closing.

How should I use this ITGR AI trading strategy?

Use this ITGR AI trading strategy as a research and risk-control checklist, not a personal instruction. Confirm the live quote, the proxy and stockholder meeting schedule, regulatory milestones, position size, and your own risk limits before making any trade, and treat the $127 offer as the main reference rather than a fundamental target.

Why did ITGR stock surge in late July 2026?

ITGR surged 20.18% on July 31, 2026, closing at $121.21, after reports that KKR was near a deal to acquire the company, following a strategic review announced on April 30, 2026. The deal was confirmed on August 3, 2026 at $127 per share, and the stock rose another 2.67% to close at $124.45.

What happens to ITGR stockholders if the KKR deal closes?

If the KKR acquisition closes, ITGR stockholders will receive $127 per share in cash for each share they own, and Integer will become a privately held company whose common stock is delisted from the New York Stock Exchange. The transaction is expected to close by the end of 2026.

What is the biggest risk in ITGR AI stock analysis?

The biggest risk in ITGR AI stock analysis is that the KKR deal fails to close, which would remove the $127 offer as the price anchor and likely send the stock back toward the $95 to $100 pre-announcement range, while the underlying business shows declining sales, adjusted EBITDA down 4% in Q2 2026, and leverage of 3.2x adjusted EBITDA.

Integer Holdings Corporation research snapshot

ITGR AI Stock Analysis

ITGR AI stock analysis as of the August 4, 2026 data cutoff is anchored by a definitive agreement under which an affiliate of KKR will acquire all outstanding shares of Integer Holdings Corporation for $127 per share in cash, a transaction valued at an enterprise value of approximately $5.7 billion and announced on August 3, 2026. The stock closed at $124.45 on August 3, 2026, up 3.24 or 2.67% from the $121.21 close on July 31, when the stock jumped 20.18% on reports of a pending buyout, leaving a small spread to the $127 offer that reflects deal-close uncertainty. The offer represents a premium of about 51.8% to the April 29, 2026 close, the day before the board announced a strategic review, and about 28.8% to the 30-day VWAP as of July 31, 2026. Integer also reported second quarter 2026 results on August 3, with sales down 2.6% to $464 million, adjusted EPS up 3% to $1.60, and adjusted EBITDA down 4% to $95 million, while withdrawing its financial outlook given the pending deal. This is informational research and not investment advice, and the deal is not guaranteed to close.

Current price

$124.45 at the August 3, 2026, 4:00 PM EDT market close, up 3.24 or 2.67% from the $121.21 July 31 close, after the stock surged 20.18% on July 31 on reports of a pending buyout and then confirmed the KKR deal on August 3, with an after-hours quote of $124.52

Market cap

About $4.23 billion at the August 3, 2026 close, matching $124.45 times 33.95 million shares outstanding, while the $127 cash offer implies an equity value of about $4.31 billion and an enterprise value of about $5.7 billion including net debt

AI score

78 / 100

Rating

Definitive $127 cash offer; stock trading near the deal price

Trend status

Trading near the $127 offer and the 52-week high of $125.54 after a deal-driven surge

Data cutoff (updated monthly)

August 4, 2026

Informational use only. This page is not investment advice.

Research quality check

information Richness: B-level information richness. Integer has long SEC filing history and active analyst coverage from healthcare-focused firms, and the August 3, 2026 KKR acquisition announcement plus the second quarter 2026 earnings release added a concentrated stream of high-quality primary information. Some balance sheet and TTM figures still required reconciliation across StockAnalysis.com and company filings.
bias Check: The main AI bias risk is anchoring to the $127 offer price and treating deal completion as certain. The reverse check asks whether the deal can fail on stockholder approval, regulatory review, or the expected year-end closing timeline, and whether the stock reverts toward pre-deal levels near $95 to $100 if it does. The analysis also flags the mirror-image bias of ignoring the weak second quarter, where sales fell 2.6% and adjusted EBITDA fell 4%, and the elevated 3.2x leverage ratio that the buyer is underwriting.
ai Confidence: Medium-high for the deal terms, the August 3, 2026 quote, Q2 2026 results, market cap math, and balance sheet figures that cross-validated across the GlobeNewswire releases, StockAnalysis.com, and financial_rigor.py. The StockAnalysis.com statistics page reports TTM EPS of $3.97 and trailing PE of 31.36, while the StockAnalysis.com financials overview shows TTM EPS of $3.68 and net income of $128.4 million; both are cited with their sources, and the difference reflects slightly different trailing windows and diluted share bases. Lower confidence for the timing and certainty of deal close and for any post-deal private-market value.
investment Certainty: Medium. The $127 cash offer gives the stock a defined reference value, and the transaction is not subject to a financing contingency, but completion still requires stockholder approval and regulatory clearance, and a failed or delayed deal would likely send the stock back toward the pre-announcement range near $95 to $100.

Quick verdict table

Dimension	Conclusion	Confidence
Business quality	Integer is a leading medical device contract development and manufacturing organization with strong positions in cardiac rhythm management, neuromodulation, and cardio and vascular components. Second quarter 2026 sales fell 2.6% to $464 million with organic sales down 1.5%, reflecting the impact of three new customer products.	Medium-high
Moat	Moat comes from regulatory barriers for implantable component manufacturing, proprietary battery and feedthrough technology, global manufacturing scale, and long-term OEM supply agreements that create switching costs.	Medium
Management	The board ran a strategic review announced April 30, 2026 and agreed to a $127 per share all-cash acquisition by KKR, with the board unanimously approving and recommending the transaction. CEO Payman Khales leads the company through the pending close.	Medium
Financial trend	FY2025 revenue reached $1.854 billion, up 7.98%, with net income of $102.81 million. Q2 2026 sales fell 2.6% to $464 million, adjusted EPS rose 3% to $1.60, adjusted EBITDA fell 4% to $95 million, and net leverage reached 3.2x adjusted EBITDA.	Medium-high
Valuation	The $127 cash offer values the equity at about $4.31 billion and the enterprise at about $5.7 billion. The stock trades at about 31.4x trailing EPS, 18.6x forward EPS, 2.3x sales, and 42.3x trailing free cash flow, all below the deal price anchor.	Medium
Technical trend	ITGR surged 20.18% on July 31 to $121.21 on buyout reports and closed at $124.45 on August 3, near the 52-week high of $125.54 and just below the $127 offer, with RSI near 85 signaling overbought conditions after the move.	Medium
Risk level	Key risks are deal completion risk from stockholder approval, regulatory review, and the year-end closing timeline, plus customer concentration, OEM consolidation, procedure volume cyclicality, and a 3.2x net leverage ratio.	Medium-high
AI confidence	Medium-high for deal terms, the quote, Q2 2026 results, market cap math, and valuation ratios that cross-validated across company releases, StockAnalysis.com, and financial_rigor.py. Lower confidence for deal timing and completion odds.	Medium-high data confidence
Investment certainty	Medium. The $127 cash offer anchors value near the current price, but the deal is not guaranteed to close, and the modest 2% spread to the offer leaves little upside for holders while deal failure carries meaningful downside.	Medium

ITGR AI stock forecast

ITGR AI Stock Forecast Scenarios

The ITGR AI stock forecast is now structured around the KKR acquisition rather than a standalone earnings forecast. The $127 cash offer caps the normal upside, so scenarios depend on whether the deal closes, is delayed, or fails. It does not claim that AI can predict a specific future price, and completion requires stockholder and regulatory approvals with a target close by year-end 2026.

Bullish case

$127 to $132

More likely if the acquisition closes at $127 per share by year-end 2026 without a competing bid, or if a higher bid emerges during the stockholder consideration period, which would push the stock above the current offer.

Base case

$120 to $127

More likely if the stock trades in a tight band between the $124.45 August 3 close and the $127 offer as the proxy statement, stockholder vote, and regulatory review progress, with the spread narrowing as the expected close approaches.

Bearish case

$90 to $110

More likely if the deal is terminated, blocked, or materially delayed, sending the stock back toward the pre-announcement trading range near $95 to $100, which was the 30-day VWAP reference point behind the offer.

ITGR AI technical analysis

ITGR AI Technical Analysis

ITGR AI technical analysis starts from the $124.45 close on August 3, 2026. The stock gapped from a $100.86 July 30 close to $121.21 on July 31 on the buyout report, then rose to $124.45 on August 3, trading right below the $125.54 52-week high and the $127 offer. Because this page does not fetch request-time market data, traders should confirm levels on a live chart and monitor deal news before acting.

Level	Value	Why it matters
Current price	$124.45	Close on August 3, 2026, up 2.67%, after the stock jumped 20.18% on July 31. After-hours quote was $124.52.
Near support	$120 to $121	The July 31 close at $121.21 and the round-number zone form the first support. A daily close below this area would signal fading deal optimism.
Secondary support	$113 to $116	The gap-fill area between the July 30 close near $100.86 and the July 31 high. A sustained break below would point to a return toward pre-deal levels.
Major support	$95 to $100	The 30-day VWAP reference behind the offer and the pre-announcement trading range. This zone matters only if the deal breaks.
Near resistance	$125.54 to $127	The 52-week high of $125.54 and the $127 cash offer form the resistance ceiling. The stock cannot sustainably trade far above the offer without a competing bid.
50-day moving average	About $94.46	Well below the current price because the deal gap moved the stock sharply higher. It is a long-term reference rather than an active trading level.
200-day moving average	About $85.12	Far below the current price. The 200-day average is not relevant until the stock reverts toward pre-deal levels.
Momentum	RSI near 85, overbought	The 14-day RSI near 84.86 reflects the two-day deal surge and warns that the move is stretched and vulnerable to headline-driven swings.
Volume	About 12.6 million shares	August 3 volume was about 12.6 million shares against a 20-day average near 1.15 million, confirming institutional participation in the deal news.
Volatility	ATR elevated near $5 to $8	Daily ranges widened dramatically around the July 31 gap. Position sizing should allow for large swings on deal headlines.
Invalidation	Close below $120, then $113	A close below $120 weakens the deal-optimism setup. A break below $113 to $116 would signal a return toward pre-deal levels and raise deal-failure risk.

ITGR AI trading strategy

ITGR AI Trading Strategy Framework

The ITGR AI trading strategy is now primarily an event-driven deal framework rather than a classic trend or mean-reversion strategy. It combines the $127 cash offer reference, technical confirmation, deal-monitoring, position sizing, and clear invalidation levels.

Deal-spread framework

For holders, the $127 cash offer defines the reference value. The stock closed at $124.45 on August 3, about 2% below the offer. Monitor the proxy statement, the stockholder vote, regulatory review, and the expected year-end close to assess whether the spread should narrow.

Define maximum loss per position as if the deal could fail. A widening spread or negative deal news should reduce confidence before the close.

Pullback entry framework

If ITGR pulls back toward $120 to $121 without breaking the deal thesis, the spread to the $127 offer widens and the risk-reward improves for investors who underwrite deal completion. Confirmation requires the pullback to hold and deal milestones to stay on schedule.

Do not chase the stock above the offer price. Set a stop below $113 to $116 if the deal shows signs of stress.

Deal-failure monitor

Track the proxy filing, stockholder meeting date, any competing bids, antitrust and regulatory commentary, and statements from KKR and Integer. Also monitor Q3 sales trends, segment performance, and the leverage ratio in case the deal closes and the business must be assessed on fundamentals.

If the deal is terminated or blocked, the fundamental reference returns to the business, which trades at about 31x trailing EPS with sales down 2.6% in Q2 2026 and leverage at 3.2x, pointing to a likely reversion toward $95 to $100.

Investment research summary

Four-master Research Compression

Business essence

Integer manufactures critical components and finished devices for medical device OEMs, including implantable pacemaker batteries, defibrillator components, neuromodulation devices, and catheters used in cardiac and vascular procedures, under the Greatbatch Medical and Lake Region Medical brands.

Moat

Integer benefits from regulatory barriers that make it hard for OEMs to requalify a supplier, proprietary battery and feedthrough technology for implantable devices, global manufacturing scale, and long-term supply agreements with major medtech customers.

Munger risk inversion

The investment thesis fails if the KKR deal is terminated or blocked, if medtech OEMs consolidate suppliers, if a major manufacturing program is lost, if procedure volumes decline, or if the 3.2x leverage and weak Q2 sales make the business less attractive than the offer implies.

Management

The board announced a strategic review on April 30, 2026 and on August 3, 2026 agreed to a definitive $127 per share all-cash acquisition by KKR. The transaction is not subject to a financing contingency, and the board unanimously recommends stockholder approval.

Industry trend

Integer operates in the medical device outsourcing market, which benefits from aging populations, minimally invasive procedures, and OEM preference for specialized contract manufacturers. KKR agreed to the deal partly to fund capacity, technology, and talent growth in those end markets.

Valuation and margin of safety

At the $124.45 close, the stock trades about 2% below the $127 cash offer, so the margin of safety is now a deal-close margin rather than a fundamental margin. The offer is about 51.8% above the April 29, 2026 close and about 28.8% above the 30-day VWAP as of July 31, 2026.

Source-backed data

ITGR Data Table

Every metric below includes a source and last verification date.

Metric	Value	Source	Last verified
ITGR price	$124.45 at the August 3, 2026, 4:00 PM EDT market close, up 3.24 or 2.67% from the $121.21 July 31 close, with an after-hours quote of $124.52, a 52-week range of $62.00 to $125.54, and August 3 volume near 12.6 million shares	StockAnalysis.com real-time quote and daily price history	August 4, 2026
KKR acquisition terms	$127 per share in cash for all outstanding shares, enterprise value of approximately $5.7 billion, premium of about 51.8% to the April 29, 2026 close and about 28.8% to the 30-day VWAP as of July 31, 2026, expected close by end of 2026 subject to stockholder approval and regulatory approvals, and not subject to a financing contingency	Integer and KKR press release via GlobeNewswire	August 4, 2026
Second quarter 2026 results	Sales of $464 million, down 2.6% with organic sales down 1.5%, GAAP diluted EPS of $0.69, adjusted EPS of $1.60 up 3%, adjusted EBITDA of $95 million down 4%, and Cardio and Vascular sales of $280 million down 2.3%	Integer Q2 2026 earnings release via GlobeNewswire	August 4, 2026
Debt and leverage	Total debt increased $53 million to $1.238 billion, non-GAAP net total debt of $1.236 billion, and a leverage ratio of 3.2 times adjusted EBITDA as of July 3, 2026	Integer Q2 2026 earnings release	August 4, 2026
Balance sheet	Cash and cash equivalents of $21.375 million, total assets of $3.424 billion, long-term debt of $1.238 billion, and stockholders equity of $1.719 billion as of July 3, 2026	Integer Q2 2026 earnings release condensed balance sheet	August 4, 2026
Market capitalization	About $4.23 billion at the August 3, 2026 close, verified as $124.45 times 33.95 million shares outstanding by financial_rigor.py with 0.12% deviation from the reported figure, and about $4.31 billion implied by the $127 offer	financial_rigor.py market cap verification and StockAnalysis.com	August 4, 2026
Enterprise value	$5.60 billion per StockAnalysis.com statistics, consistent with the roughly $5.7 billion transaction value including net debt of about $1.24 billion	StockAnalysis.com statistics and Integer Q2 2026 earnings release	August 4, 2026
FY2025 financials	Revenue of $1.854 billion, up 7.98% from $1.717 billion, net income of $102.81 million down 14.25% from $119.9 million, and diluted EPS of $2.89	StockAnalysis.com financials	August 4, 2026
TTM financials	TTM revenue of about $1.84 billion, TTM net income of about $128 million, and TTM EPS of $3.68 per the StockAnalysis.com financials overview, which reflects the weaker second quarter	StockAnalysis.com financials	August 4, 2026
Revenue trend	FY2021 revenue of $1.221 billion, FY2022 of $1.331 billion, FY2023 of $1.556 billion, FY2024 of $1.717 billion, and FY2025 of $1.854 billion, with 9.03%, 16.85%, 10.35%, and 7.98% annual growth over the last four fiscal years	StockAnalysis.com financials	August 4, 2026
Valuation math	31.36x trailing PE, 18.62x forward PE, 2.28x sales, 2.49x book value, 42.34x trailing free cash flow, and 17.67x EV/EBITDA at the $124.45 close, verified via financial_rigor.py	financial_rigor.py valuation verification and StockAnalysis.com	August 4, 2026
Analyst consensus	Hold with an average target of $112.14 across 10 analysts, low $95 and high $127, with several firms moving to Hold or equivalent ratings after the deal was announced	StockAnalysis.com forecast and ratings	August 4, 2026
Post-deal analyst actions	Truist and Piper Sandler moved to Hold with $127 targets, KeyBanc to Sector Weight, Raymond James to Market Perform, Oppenheimer to Perform, and BofA to No Rating after the August 3 acquisition announcement	StockAnalysis.com forecast and ratings	August 4, 2026
Shares outstanding and float	33.95 million shares outstanding with about 33.46 million in the float, insider ownership of 1.44%, institutional ownership reported at 116.66%, and short interest of 4.35 million shares equal to 12.82% of shares outstanding	StockAnalysis.com statistics	August 4, 2026
Technical snapshot	50-day moving average about $94.46, 200-day moving average about $85.12, 14-day RSI near 84.86, 20-day average volume near 1.15 million shares, and beta of 0.61	StockAnalysis.com statistics	August 4, 2026
Management	President and CEO Payman Khales and CFO Diron Smith, with the board chaired through the strategic review that produced the KKR agreement	StockAnalysis.com company profile	August 4, 2026

Frequently Asked Questions

Read the NVDA AI stock analysis View MMSI AI stock analysis Explore HAE AI stock analysis Explore AI Stock Picker Generate an AI trading strategy Screen stocks with Pineify

This ITGR AI stock analysis is an informational tool for research and education only. It is not investment advice, a recommendation, or a guarantee of future performance, and it does not confirm that the KKR acquisition will close. Forecast ranges are scenarios based on available data as of August 4, 2026 and can be wrong, especially around deal timing, regulatory decisions, and stockholder votes.